Literature DB >> 19520193

Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules.

Geneviève Langlois1, Julie Dusseault, Stéphanie Bilodeau, Susan K Tam, Dalla Magassouba, Jean-Pierre Hallé.   

Abstract

Alginate purification has been shown to decrease the host immune response to implanted alginate-based microcapsules, but the direct effect of contaminants on islet cell survival remains unknown. Wistar rat islets were immobilized in calcium alginate beads made with crude vs. purified alginate and then incubated in CMRL culture medium. Islet survival was evaluated at 1, 4, 7, 14 and 27 days post-encapsulation. Islet viability was investigated using a dual staining assay (propidium iodide and orange acridine). The islet cell necrosis and the proportion of apoptotic cells were quantified under optical microscopy and with a TUNEL assay, respectively. Islets immobilized in purified alginate were more viable, and had fewer necrotic centers, a smaller area of central necrosis and a lower number of apoptotic cells. At day 14 and 27 post-encapsulation, respectively, 48% and 23% of islets were viable with purified alginate vs. 18% and 8% with crude alginate (p<0.05). At day 14, the surface area of central necrosis and the number of necrotic islets were more important with the impure alginate (65% vs. 45% and 73% vs. 53%, respectively; p<0.05). We conclude that alginate purification improves the survival of islets that are immobilized in alginate-based microcapsules. These findings indicate that caution should be taken in the interpretation of in vivo experiments, as the results could be explained by either a direct effect on islet survival or a modification of the host reaction, or both. Moreover, it suggests that the effect on islet viability should be assessed during the development of biomaterials for cell encapsulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520193     DOI: 10.1016/j.actbio.2009.05.029

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  13 in total

1.  Hyaluronic Acid/Collagen Hydrogel as an Alternative to Alginate for Long-Term Immunoprotected Islet Transplantation<sup/>.

Authors:  Stephen Harrington; Janette Williams; Sonia Rawal; Karthik Ramachandran; Lisa Stehno-Bittel
Journal:  Tissue Eng Part A       Date:  2017-03-02       Impact factor: 3.845

Review 2.  Islet transplantation and encapsulation: an update on recent developments.

Authors:  Vijayaganapathy Vaithilingam; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2011-05-10

Review 3.  Islet and stem cell encapsulation for clinical transplantation.

Authors:  Rahul Krishnan; Michael Alexander; Lourdes Robles; Clarence E Foster; Jonathan R T Lakey
Journal:  Rev Diabet Stud       Date:  2014-05-10

4.  Improving covalent cell encapsulation with temporarily reactive polyelectrolytes.

Authors:  C M Gardner; M A Potter; H D H Stöver
Journal:  J Mater Sci Mater Med       Date:  2011-12-17       Impact factor: 3.896

5.  Improved BALB/c mice granulosa cell functions using purified alginate scaffold.

Authors:  N Zareifard; A Soleimani; T Talaei-Khozani; S Bahmanpour
Journal:  Iran J Vet Res       Date:  2018       Impact factor: 1.376

6.  Optimization of alginate purification using polyvinylidene difluoride membrane filtration: Effects on immunogenicity and biocompatibility of three-dimensional alginate scaffolds.

Authors:  Hugo P Sondermeijer; Piotr Witkowski; David Woodland; Tetsunori Seki; Frank J Aangenendt; Arnoud van der Laarse; Silviu Itescu; Mark A Hardy
Journal:  J Biomater Appl       Date:  2016-04-25       Impact factor: 2.646

7.  Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation.

Authors:  Cyrus Jahansouz; Cameron Jahansouz; Sean C Kumer; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-15

8.  Development of in vitro 3D TissueFlex® islet model for diabetic drug efficacy testing.

Authors:  Zhaohui Li; He Sun; Jianbin Zhang; Haijiao Zhang; Fanyu Meng; Zhanfeng Cui
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

9.  Establishment of Insulin-Producing Cells From Human Embryonic Stem Cells Underhypoxic Condition for Cell Based Therapy.

Authors:  Piyaporn Rattananinsruang; Chavaboon Dechsukhum; Wilairat Leeanansaksiri
Journal:  Front Cell Dev Biol       Date:  2018-05-15

Review 10.  Stem Cell Therapy for Diabetes: Beta Cells versus Pancreatic Progenitors.

Authors:  Bushra Memon; Essam M Abdelalim
Journal:  Cells       Date:  2020-01-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.